Standout Papers
Citation Impact
Citing Papers
2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults
2013 Standout
Guidelines for the Management of Spontaneous Intracerebral Hemorrhage
2015 Standout
Shear-induced unfolding triggers adhesion of von Willebrand factor fibers
2007 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack
2014 Standout
Size regulation of von Willebrand factor–mediated platelet thrombi by ADAMTS13 in flowing blood
2005
Rationally Designed Integrin β3 Mutants Stabilized in the High Affinity Conformation
2008 StandoutNobel
Point-of-care bulk testing for SARS-CoV-2 by combining hybridization capture with improved colorimetric LAMP
2021 StandoutNobel
ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
2007
Biological functions of fucose in mammals
2017
A Polymer-Based, Paclitaxel-Eluting Stent in Patients with Coronary Artery Disease
2004 Standout
Cardiac ischemia during hemolytic uremic syndrome
2003
Prothrombotic Coagulation Abnormalities Preceding the Hemolytic–Uremic Syndrome
2002
Von Willebrand factor, platelets and endothelial cell interactions
2003
ABO and P1 Blood Group Antigen Expression andstxGenotype and Outcome of ChildhoodEscherichia coliO157:H7 Infections
2002
Oral Anticoagulant Therapy
2012 Standout
Heterogeneously Hybridized Porous Coordination Polymer Crystals: Fabrication of Heterometallic Core–Shell Single Crystals with an In‐Plane Rotational Epitaxial Relationship
2008 StandoutNobel
New Antithrombotic Drugs
2012
The Primary and Secondary Prevention of Coronary Artery Disease
2008
Emergency Hospitalizations for Adverse Drug Events in Older Americans
2011 Standout
Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome
2005 Standout
Solution Structure of Human von Willebrand Factor Studied Using Small Angle Neutron Scattering
2006
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
2009 Standout
The role of von Willebrand factor in thrombus formation
2007
Late coronary stent thrombosis: Early vs. late stent thrombosis in the stent era
2002
Platelets in atherothrombosis
2002
Bleeding due to disruption of a cargo-specific ER-to-Golgi transport complex
2003
Human and mouse proteases: a comparative genomic approach
2003
Coronary Artery Stents
2000
Platelet Activation and Atherothrombosis
2007 Standout
High‐dose intravenous immunoglobulin to treat spontaneous heparin‐induced thrombocytopenia syndrome
2019
Antiplatelet Drugs
2012
A Novel PF4-Dependent Platelet Activation Assay Identifies Patients Likely to Have Heparin-Induced Thrombocytopenia/Thrombosis
2016
Recommendations for the use of LDL apheresis
2008
Initial sequence of the chimpanzee genome and comparison with the human genome
2005 StandoutNature
Autoimmune heparin‐induced thrombocytopenia
2017
Antithrombotic Therapy for Non–ST-Segment Elevation Acute Coronary Syndromes
2008
Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, Part 1: Prevention
2009
Idarucizumab for Dabigatran Reversal
2015 Standout
Escherichia coliO157:H7 Infections: Discordance between Filterable Fecal Shiga Toxin and Disease Outcome
2002
Antithrombotic Therapy in Patients Undergoing Percutaneous Coronary Intervention
2001
The P2Y12 receptor regulates microglial activation by extracellular nucleotides
2006 StandoutNobel
Thrombogenic alleles, Escherichia coli O157:H7 infections, and hemolytic uremic syndrome
2001
Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study
2001 Standout
Cyclooxygenase Inhibitors and the Antiplatelet Effects of Aspirin
2001 Standout
Extracellular mRNA Induces Dendritic Cell Activation by Stimulating Tumor Necrosis Factor-α Secretion and Signaling through a Nucleotide Receptor
2002 StandoutNobel
Cranio-lenticulo-sutural dysplasia is caused by a SEC23A mutation leading to abnormal endoplasmic-reticulum-to-Golgi trafficking
2006 StandoutNobel
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
Bifidobacteria can protect from enteropathogenic infection through production of acetate
2011 StandoutNature
Long-term outcomes associated with hospital acquired thrombocytopenia among patients with non–ST-segment elevation acute coronary syndrome
2014
Identification of the platelet ADP receptor targeted by antithrombotic drugs
2001 StandoutNatureNobel
Clinical picture of heparin-induced thrombocytopenia (HIT) and its differentiation from non-HIT thrombocytopenia
2016
Platelet-Active Drugs
2001
Small RNAs are modified with N-glycans and displayed on the surface of living cells
2021 StandoutNobel
Hydrogen storage in metal–organic frameworks
2009 Standout
Platelet-Active Drugs: The Relationships Among Dose, Effectiveness, and Side Effects
2004
Cleavage of ultra‐large von Willebrand factor by ADAMTS‐13 under flow conditions
2005
Central role of the P2Y12 receptor in platelet activation
2004
High-dose intravenous immunoglobulin for the treatment and prevention of heparin-induced thrombocytopenia: a review
2019
Extracellular DNA traps promote thrombosis
2010 Standout
High-Capacity Hydrogen and Nitric Oxide Adsorption and Storage in a Metal−Organic Framework
2007
Mice deficient in LMAN1 exhibit FV and FVIII deficiencies and liver accumulation of α1-antitrypsin
2011 StandoutNobel
Hydrogen Storage in Metal–Organic Frameworks
2011 Standout
Effects of Clopidogrel in Addition to Aspirin in Patients with Acute Coronary Syndromes without ST-Segment Elevation
2001 Standout
Deep Eutectic Solvents (DESs) and Their Applications
2014 Standout
Platelets in Inflammation and Thrombosis
2003
Guidelines for Prevention of Stroke in Patients With Ischemic Stroke or Transient Ischemic Attack
2006 Standout
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Safety and Tolerability of Antiplatelet Therapies for the Secondary Prevention of Atherothrombotic Disease
2009
2012 Update to The Society of Thoracic Surgeons Guideline on Use of Antiplatelet Drugs in Patients Having Cardiac and Noncardiac Operations
2012
The Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) trial programme. Rationale, design and baseline characteristics including a meta-analysis of the effects of thienopyridines in vascular disease
2000
Role of Prostacyclin in the Cardiovascular Response to Thromboxane A 2
2002 StandoutScience
Novel Platelet Inhibitors
2001
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Oral Rivaroxaban for the Treatment of Symptomatic Pulmonary Embolism
2012 Standout
Clinical End Points in Coronary Stent Trials
2007 Standout
Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection
2020
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination
2021 Standout
Selective NO Trapping in the Pores of Chain-Type Complex Assemblies Based on Electronically Activated Paddlewheel-Type [Ru2II,II]/[Rh2II,II] Dimers
2013 StandoutNobel
Soluble plasma-derived von Willebrand factor assembles to a haemostatically active filamentous network
2007
Relative Nephroprotection DuringEscherichia coliO157:H7 Infections: Association With Intravenous Volume Expansion
2005
Metal–Organic Frameworks for Separations
2011 Standout
A prospective, blinded study of a PF4-dependent assay for HIT diagnosis
2020
Metal–Organic Frameworks in Biomedicine
2011 Standout
NO-Releasing Zeolites and Their Antithrombotic Properties
2005
Engineering Metal Organic Frameworks for Heterogeneous Catalysis
2010 Standout
Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination
2021 Standout
Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack
2010 Standout
Guideline-concordant administration of prothrombin complex concentrate and vitamin K is associated with decreased mortality in patients with severe bleeding under vitamin K antagonist treatment (EPAHK study)
2014
High-Dose Atorvastatin after Stroke or Transient Ischemic Attack
2006 Standout
Adhesion Mechanisms in Platelet Function
2007
Hematological Problems in Pediatric Intensive Care
2013 Standout
Weekend versus Weekday Admission and Mortality from Myocardial Infarction
2007 Standout
2012 ACCF/AHA Focused Update Incorporated Into the ACCF/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction
2013
Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination
2021 Standout
Works of Ravi Sarode being referenced
How do I transfuse platelets (PLTs) to reverse anti‐PLT drug effect? (CME)
2011
Prevention and treatment of bleeding complications in patients receiving vitamin K antagonists, part 2: Treatment
2009
Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura
2001 StandoutNature
Suboptimal effect of a three‐factor prothrombin complex concentrate (Profilnine‐SD) in correcting supratherapeutic international normalized ratio due to warfarin overdose
2009
Intravenous immunoglobulin as an adjunct therapy in persisting heparin-induced thrombocytopenia
2018
Thrombotic Thrombocytopenic Purpura Associated with Clopidogrel
2000
Von Willebrand Factor and Von Willebrand Factor-Cleaving Metalloprotease Activity in Escherichia coli O157:H7-Associated Hemolytic Uremic Syndrome
2001
Saliva for use with a point of care assay for the rapid diagnosis of COVID-19
2020
Guidelines on the use of therapeutic apheresis in clinical practice—Evidence‐based approach from the apheresis applications committee of the American society for apheresis
2007
Five hematologic tests and treatments to question
2014
Delayed-onset heparin-induced thrombocytopenia, venous thromboembolism, and cerebral venous thrombosis: A consequence of heparin “flushes”
2007
Warfarin-induced venous limb ischemia/gangrene complicating cancer: a novel and clinically distinct syndrome
2015
2017 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants
2017
Efficacy and Safety of a 4-Factor Prothrombin Complex Concentrate in Patients on Vitamin K Antagonists Presenting With Major Bleeding
2013